Fundraising Fox
/Companies
Sign in

QuanDx

San Jose, US · Founded 2012 · California corporation

Find your way into QuanDx

Sign up to see every warm intro you have to QuanDx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the QuanDx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

QuanDx develops molecular diagnostic kits for detecting fusion genes in hematologic malignancies including leukemia, designed to reduce time and cost compared to traditional methods like FISH and RT-PCR. The company serves clinical and research laboratories performing leukemia diagnosis and prognosis assessment.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

XL
Xiaojun LeiExecutive

Board

GY
Guoliang YuBoard director
CL
Chunlin LiangBoard director
PC
Peng ChengBoard director

Reported raises · per SEC filings

Form D private placements

$4M disclosed across 2 rounds · 2013–2015

▶$3MraisedDec 2015 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chunlin LiangDirector
  • Guoliang YuDirector
  • Peng ChengDirector
  • Xiaojun LeiExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
First sale
Nov 2015
Incorporated
Corporation, California, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$950KraisedJan 2014 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Guoliang YuDirector
  • Xiaojun LeiExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$950K
First sale
Dec 2013
Incorporated
Corporation, California, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does QuanDx do?
QuanDx develops molecular diagnostic kits for detecting fusion genes in hematologic malignancies including leukemia, designed to reduce time and cost compared to traditional methods like FISH and RT-PCR. The company serves clinical and research laboratories performing leukemia diagnosis and prognosis assessment.
How much funding has QuanDx raised?
QuanDx has disclosed $4M raised across 2 rounds.
Where is QuanDx headquartered?
QuanDx is headquartered in San Jose, US.